Literature DB >> 24105332

The healing of alkali-injured cornea is stimulated by a novel matrix regenerating agent (RGTA, CACICOL20): a biopolymer mimicking heparan sulfates reducing proteolytic, oxidative and nitrosative damage.

Jitka Cejkova1, Celine Olmiere2, Cestmir Cejka3, Peter Trosan4, Vladimir Holan4.   

Abstract

The efficacy of a chemically modified dextran - heparan sulfate mimicking regenerating agent (RGTA) on the healing of the rabbit cornea injured with alkali was examined. The eyes were injured with 0.15 N NaOH applied on the cornea or with 1.0 N NaOH using a 8 mm diameter filter paper disk. Then RGTA or placebo was applied on the cornea. In the last group of rabbits, corneas injured with the high alkali concentration were left without any treatment for four weeks; subsequently, the corneas were treated with RGTA or placebo. The central corneal thickness was measured using a pachymeter. The corneas were examined morphologically, immunohistochemically and for real time-PCR. Compared to control (unaffected) corneas, following the application of low alkali concentration the expression of urokinase-type plasminogen activator, metalloproteinase 9, nitric oxide synthase and xanthine oxidase was increased in the injured corneal epithelium of placebo-treated eyes, whereas the expression of antioxidant enzymes was reduced. Nitrotyrosine and malondialdehyde stainings appeared in the corneal epithelium. RGTA application suppressed the antioxidant/prooxidant imbalance and reduced the expression of the above-mentioned immunohistochemical markers. The corneal thickness increased after alkali injury, decreased during corneal healing after RGTA treatment faster than after placebo application. Following the injury with the high alkali concentration, corneal inflammation and neovascularization were highly pronounced in placebo-treated corneas, whereas in RGTA-treated corneas they were significantly supressed. When RGTA or placebo application was started later after alkali injury and corneas were ulcerated, subsequent RGTA treatment healed the majority of them. In conclusion, RGTA facilitates the healing of injured corneas via a reduction of proteolytic, oxidative and nitrosative damage.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24105332     DOI: 10.14670/HH-29.10.457

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  14 in total

1.  Polymeric nanocapsules: a potential new therapy for corneal wound healing.

Authors:  Sonia Reimondez-Troitiño; Ignacio Alcalde; Noemi Csaba; Almudena Íñigo-Portugués; María de la Fuente; Federico Bech; Ana C Riestra; Jesús Merayo-Lloves; María J Alonso
Journal:  Drug Deliv Transl Res       Date:  2016-12       Impact factor: 4.617

Review 2.  An update on chemical eye burns.

Authors:  Mukhtar Bizrah; Ammar Yusuf; Sajjad Ahmad
Journal:  Eye (Lond)       Date:  2019-05-13       Impact factor: 3.775

3.  Corneal matrix repair therapy with the regenerating agent in neurotrophic persistent epithelial defects.

Authors:  Canan Asli Utine; Ceren Engin Durmaz; Nilufer Koçak
Journal:  Int J Ophthalmol       Date:  2017-12-18       Impact factor: 1.779

Review 4.  Chemical eye injury: pathophysiology, assessment and management.

Authors:  Harminder S Dua; Darren Shu Jeng Ting; Ahmed Al Saadi; Dalia G Said
Journal:  Eye (Lond)       Date:  2020-06-22       Impact factor: 3.775

5.  Impairment of corneal epithelial wound healing is association with increased neutrophil infiltration and reactive oxygen species activation in tenascin X-deficient mice.

Authors:  Takayoshi Sumioka; Hiroki Iwanishi; Yuka Okada; Masayasu Miyajima; Kana Ichikawa; Peter S Reinach; Ken-Ichi Matsumoto; Shizuya Saika
Journal:  Lab Invest       Date:  2021-03-29       Impact factor: 5.662

6.  Use of Plasma Rich in Growth Factors and ReGeneraTing Agent Matrix for the Treatment of Corneal Diseases.

Authors:  Ronald M Sánchez-Ávila; Edmar Uribe-Badillo; Carlos Fernández-Vega González; Francisco Muruzabal; Borja de la Sen-Corcuera; Begoña Baamonde; Luis M Quirós; Eduardo Anitua; Jesús Merayo-Lloves
Journal:  Vision (Basel)       Date:  2021-07-02

7.  A pharmacological modification of pain and epithelial healing in contemporary transepithelial all-surface laser ablation (ASLA).

Authors:  Ioannis M Aslanides; Vasilis D Selimis; Nikolaos V Bessis; Panagiotis N Georgoudis
Journal:  Clin Ophthalmol       Date:  2015-04-15

8.  Treatment of Acanthamoeba neurotrophic corneal ulcer with topical matrix therapy.

Authors:  Antonio Mateo; Beatriz Abadía; Pilar Calvo; Enrique Minguez; Luis Pablo; José Manuel Benitez Del Castillo
Journal:  J Ophthalmic Inflamm Infect       Date:  2015-06-21

Review 9.  Oxidative stress to the cornea, changes in corneal optical properties, and advances in treatment of corneal oxidative injuries.

Authors:  Cestmir Cejka; Jitka Cejkova
Journal:  Oxid Med Cell Longev       Date:  2015-03-11       Impact factor: 6.543

Review 10.  Matrix regenerative therapy.

Authors:  Cristina-Mihaela Timaru; Cornel Stefan; Daniela Adriana Iliescu; Algerino De Simone; Mehdi Batras
Journal:  Rom J Ophthalmol       Date:  2017 Jan-Mar
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.